DOC · Healthpeak Properties, Inc.

Track DOC — free

$20.82 +0.00 (+0.00%) At close · Sep 1

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$14.38B

689.53M

Up next

Next earnings call

Nov 5, 2026 Est · unconfirmed · in 9 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 5, 2026

Equibles Research

our published analysis of this company

Research Thesis July 14, 2026

Alexandria Real Estate Equities: stress event priced in, dividend reset is the test

Alexandria Real Estate Equities sits at a -38.8% trailing-twelve-month change and a -45.0% drawdown from its 52-week high after cutting its dividend from $1.32 to $0.72 and reporting zero public biotech leasing for the first quarter in company history. The peer office REIT cohort is reporting tightening markets and raising FFO midpoints, leaving ARE's stress specific to its public-biotech exposure — the setup turns on whether the 1.1 million square feet of leased vacant space delivers in September 2026, the $2.2 billion disposition program closes on pace, and public biotech leasing returns in Q2.

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Weak Quant / Vol Low

Market backdrop VIX 16.3 · calm Equity put/call 0.67

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +12%

above

Price vs 50-day avg −3%

below

RSI (14) 43

neutral

MACD trend Negative

52-week position 72%

mid-range

Momentum

relative strength

Strong

1-month return −4%

trailing

6-month return +22%

trailing

YTD return +29%

this year

Relative strength +9%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $22 › 200d $19 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +99 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.26% of float · ▼ -7.9% MoM · 3.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

758 holders — near 3-yr high, broad support

Squeeze score 49

elevated · 0–100

Fundamentals

Weak

Revenue growth +5%

Y/Y

EPS growth −72%

Y/Y

Valuation P/E 59.6

in line

Buyback $500.0M

authorized

Balance sheet $9.4B

net debt

Quant / Vol

risk profile

Low

Volatility 29%

annualized · 1-yr

Max drawdown −19%

past year

ATR 2.0%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+12% Bullish

Price vs 50-day avg

−3% Neutral

RSI (14)

43 Neutral

MACD trend

Negative Bearish

52-week position

72% Neutral

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $22 › 200d $19 — 50d above 200d

Institutional flow Distributing

-1% holders QoQ · +99 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.26% of float · ▼ -7.9% MoM · 3.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

758 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $16 Now $21 · 72% Range high $23

vs 200-day avg +12% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

REIT - Healthcare Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
DOC Healthpeak Properties, Inc. this stock	$14.38B	+29.5%	+4.5%	59.6	3.3%
WELL Welltower Inc.	$165.97B	+29.5%	+35.6%	117.0	2.5%
VTR Ventas, Inc.	$47.09B	+19.0%	+18.5%	170.0	4.6%
OHI Omega Healthcare Investors Inc	$13.94B	+5.5%	+13.2%	16.4	4.0%
AHR American Healthcare REIT, Inc.	$12.04B	+20.1%	+9.1%	80.0	13.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

758

% held: 96.1%
Net QoQ: -24.3M sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

601

View

Short & Settlement

Short Interest Falling

Shares short

22.5M

Days to cover: 3.9d
Change: -1.9M sh

View

Short Volume

Short vol %

63%

As of: Sep 1, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $735
As of: Aug 5, 2026

View

Off-Exchange

Off-exchange %

41.3%

Week of: Jul 27, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Buy

Member

Alan Armstrong

Amount: $1.0K–$15.0K
Traded: Mar 27, 2026

View

Financials

Revenue (FY)

$2.8B

Net income (FY): $71.3M
EPS diluted: $0.10

View

Buybacks

Authorized

$500.0M

View

Filings

SEC Filings

Latest

10-Q

Filed: Aug 5, 2026
This year: 10

View

Proposed Sales

Value

$213.7K

Shares: 11.0K
Filed: May 12, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 5, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
DOC	-3.9%	-3.7%	+22.0%	+0.0%	+29.5%
SPY	-0.5%	-1.2%	+12.6%	-0.7%	+11.7%
vs SPY	-3.3%	-2.5%	+9.3%	+0.7%	+17.8%

Capital returns

Latest dividend

$0.102 / share · ex Aug 17, 2026

Declared · upcoming

$0.1017 / share · ex Sep 14, 2026

Cut 66.6%

Paid (TTM)

$1.224 / share · 12 payouts

Dividend yield (TTM, derived)

5.88%

Buyback program · as of Jul 30, 2026

Authorized

$500.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 765880 CUSIP 42250P103 13F (30d) 490 filings 485 filers Visit website Investor relations

DOC · Healthpeak Properties, Inc.

Price & Indicators

Up next

Equibles Research

Equibles Rating

Technicals

Versus peers

At a glance

Performance

Capital returns